BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 8679334)

  • 1. [Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].
    Yamada SM; Bruner JM; Berger MS; Morrison RS
    No To Shinkei; 1996 Apr; 48(4):363-70. PubMed ID: 8679334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of fibroblast growth factor receptor 1 expression in human glioblastoma cell contributes to the cell growth suppression].
    Yamada SM; Yamaguchi F; Morrison RS; Takahashi H; Teramoto A
    No To Shinkei; 1998 Dec; 50(12):1101-5. PubMed ID: 9989355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas.
    Yamaguchi F; Morrison RS; Gonatas NK; Takahashi H; Sugisaki Y; Teramoto A
    Int J Oncol; 2003 May; 22(5):1045-9. PubMed ID: 12684670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.
    Yamaguchi F; Saya H; Bruner JM; Morrison RS
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):484-8. PubMed ID: 8290551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.
    Morrison RS; Yamaguchi F; Bruner JM; Tang M; McKeehan W; Berger MS
    Cancer Res; 1994 May; 54(10):2794-9. PubMed ID: 8168112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of frizzled 9 in astrocytomas.
    Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops.
    Hermanson M; Funa K; Hartman M; Claesson-Welsh L; Heldin CH; Westermark B; Nistér M
    Cancer Res; 1992 Jun; 52(11):3213-9. PubMed ID: 1317261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of cytokine genes within astrocytoma cell lines and brain specimens].
    Nitta T; Steinman L; Sato K
    No To Shinkei; 1991 Dec; 43(12):1145-50. PubMed ID: 1799521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas.
    Yamada SM; Yamada S; Hayashi Y; Takahashi H; Teramoto A; Matsumoto K
    Neurol Res; 2002 Apr; 24(3):244-8. PubMed ID: 11958417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma.
    Ueki T; Koji T; Tamiya S; Nakane PK; Tsuneyoshi M
    J Pathol; 1995 Dec; 177(4):353-61. PubMed ID: 8568589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of osteopontin in human glioma. Its correlation with the malignancy.
    Saitoh Y; Kuratsu J; Takeshima H; Yamamoto S; Ushio Y
    Lab Invest; 1995 Jan; 72(1):55-63. PubMed ID: 7837791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the fibroblast growth factor receptor-1 in human normal tissues and tumors determined by a new monoclonal antibody.
    Morikawa Y; Ishihara Y; Tohya K; Kakudo K; Seo MK; Matsuura N
    Arch Pathol Lab Med; 1996 May; 120(5):490-6. PubMed ID: 8639054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mdr1 mRNA expression differs between grade III astrocytomas and glioblastomas.
    Kirches E; Oda Y; Von Bossanyi P; Diete S; Schneider T; Warich-Kirches M; Dietzmann K
    Clin Neuropathol; 1997; 16(1):34-6. PubMed ID: 9020393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
    Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
    Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors.
    Jin W; McCutcheon IE; Fuller GN; Huang ES; Cote GJ
    Cancer Res; 2000 Mar; 60(5):1221-4. PubMed ID: 10728679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
    Benzil DL; Finkelstein SD; Epstein MH; Finch PW
    Cancer Res; 1992 May; 52(10):2951-6. PubMed ID: 1316231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An analysis of lymphokine gene expression within astrocytoma].
    Nitta T; Steinman L; Sato K
    No Shinkei Geka; 1992 Jul; 20(7):763-8. PubMed ID: 1630567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
    Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H
    Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.